Studies Confirm Effectiveness of Stereotactic Neurosurgery

The head frame of the new Leksell Vantage Stereotactic system is made from a novel epoxy composite material designed to improve the speed, imaging quality, and patient comfort during neurosurgery procedures.

The new Leksell Vantage system is pending 510(k) clearance by US Food and Drug Administration, but received CE (Conformité Européenne) Mark clearance in March 2017, and will now be put into clinical practice in Europe for the first time in hospitals in France, the Netherlands, the UK, and Sweden.

VP of the Neuroscience portfolio at Elekta, Jesper Söderqvist, said, "Our Leksell Stereotactic System has been helping clinicians achieve outstanding patient outcomes for more than 60 years, and Vantage improves upon this gold standard platform to deliver uncompromising accuracy in stereotactic imaging and treatment. With potential for faster imaging, more efficient workflow, reduced artifacts and a better overall user experience, Leksell Vantage is a welcome advancement for physicians and their patients."